Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P McDonnell

Showing results (261-270 of 403) with videos related to

Pageof 41
Sort By:
Cancer Letters|July 25, 2022
PPAR agonists attenuate lenalidomide's anti-myeloma activity in vitro and in vivoYonggang Sha, Jian Wu, Barry Paul, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|October 26, 1999
Infectious ulcerative keratitis after laser in situ keratomileusisP A Quiros, R S Chuck, R E Smith, et al.
Molecular Endocrinology (Baltimore, Md.)|June 28, 2007
The nuclear receptor-coactivator interaction surface as a target for peptide antagonists of the peroxisome proliferator-activated receptorsNiharika B Mettu, Thomas B Stanley, Mary A Dwyer, et al.
Cell Reports|June 20, 2019
Inhibition of ERRα Prevents Mitochondrial Pyruvate Uptake Exposing NADPH-Generating Pathways as Targetable Vulnerabilities in Breast CancerSunghee Park, Rachid Safi, Xiaojing Liu, et al.
Lupus Science & Medicine|March 7, 2024
Mezagitamab in systemic lupus erythematosus: clinical and mechanistic findings of CD38 inhibition in an autoimmune diseaseScott R P McDonnell, Van Anh Nguyen, Noah M Walton, et al.
Molecular and Cellular Biology|November 24, 1999
Dissection of the LXXLL nuclear receptor-coactivator interaction motif using combinatorial peptide libraries: discovery of peptide antagonists of estrogen receptors alpha and betaC y Chang, J D Norris, H Grøn, et al.
Molecular Cell|November 18, 2009
The homeodomain protein HOXB13 regulates the cellular response to androgensJohn D Norris, Ching-Yi Chang, Bryan M Wittmann, et al.
BMC Psychiatry|November 15, 2015
Baseline characteristics and hospitalizations in patients with schizophrenia receiving olanzapine long-acting injection: an interim analysis from a non-interventional, prospective observational safety studyMeghan E Jones, Jeffrey S Andrews, Douglas E Faries, et al.
Molecular Endocrinology (Baltimore, Md.)|October 29, 2010
Mechanisms of progesterone receptor inhibition of inflammatory responses in cellular models of breast cancerSakiko Kobayashi, James P Stice, Dmitri Kazmin, et al.
Molecular Endocrinology (Baltimore, Md.)|January 1, 1994
Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regionsM T Tzukerman, A Esty, D Santiso-Mere, et al.
Pageof 41

Showing results (261-270 of 403) with videos related to

Sort By:
Pageof 41
Cancer Letters|July 25, 2022
PPAR agonists attenuate lenalidomide's anti-myeloma activity in vitro and in vivoYonggang Sha, Jian Wu, Barry Paul, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|October 26, 1999
Infectious ulcerative keratitis after laser in situ keratomileusisP A Quiros, R S Chuck, R E Smith, et al.
Molecular Endocrinology (Baltimore, Md.)|June 28, 2007
The nuclear receptor-coactivator interaction surface as a target for peptide antagonists of the peroxisome proliferator-activated receptorsNiharika B Mettu, Thomas B Stanley, Mary A Dwyer, et al.
Cell Reports|June 20, 2019
Inhibition of ERRα Prevents Mitochondrial Pyruvate Uptake Exposing NADPH-Generating Pathways as Targetable Vulnerabilities in Breast CancerSunghee Park, Rachid Safi, Xiaojing Liu, et al.
Lupus Science & Medicine|March 7, 2024
Mezagitamab in systemic lupus erythematosus: clinical and mechanistic findings of CD38 inhibition in an autoimmune diseaseScott R P McDonnell, Van Anh Nguyen, Noah M Walton, et al.
Molecular and Cellular Biology|November 24, 1999
Dissection of the LXXLL nuclear receptor-coactivator interaction motif using combinatorial peptide libraries: discovery of peptide antagonists of estrogen receptors alpha and betaC y Chang, J D Norris, H Grøn, et al.
Molecular Cell|November 18, 2009
The homeodomain protein HOXB13 regulates the cellular response to androgensJohn D Norris, Ching-Yi Chang, Bryan M Wittmann, et al.
BMC Psychiatry|November 15, 2015
Baseline characteristics and hospitalizations in patients with schizophrenia receiving olanzapine long-acting injection: an interim analysis from a non-interventional, prospective observational safety studyMeghan E Jones, Jeffrey S Andrews, Douglas E Faries, et al.
Molecular Endocrinology (Baltimore, Md.)|October 29, 2010
Mechanisms of progesterone receptor inhibition of inflammatory responses in cellular models of breast cancerSakiko Kobayashi, James P Stice, Dmitri Kazmin, et al.
Molecular Endocrinology (Baltimore, Md.)|January 1, 1994
Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regionsM T Tzukerman, A Esty, D Santiso-Mere, et al.
Pageof 41